Application note: Role of in-house isolates in pharmaceutical quality control
Supported by:
Published: 27 November 2023
Share this post
- Like
- Digg
- Del
- Tumblr
- VKontakte
- Buffer
- Love This
- Odnoklassniki
- Meneame
- Blogger
- Amazon
- Yahoo Mail
- Gmail
- AOL
- Newsvine
- HackerNews
- Evernote
- MySpace
- Mail.ru
- Viadeo
- Line
- Comments
- Yummly
- SMS
- Viber
- Telegram
- Subscribe
- Skype
- Facebook Messenger
- Kakao
- LiveJournal
- Yammer
- Edgar
- Fintel
- Mix
- Instapaper
- Copy Link
This application note addresses the need to evaluate key sources of contamination to maintain an optimum level of pharmaceutical quality control.
Are you looking to improve your pharmaceutical quality control? Microbial contamination of pharmaceutical drugs adversely impacts their efficacy and quality presenting a significant patient risk. It is imperative to monitor the quality of the processing environment with a robust and effective environmental monitoring (EM) programme.
Download this application note by Dr Megha Bajaj, Global Solution Manager at bioMerieux, to discover more about:
- The relevancy of in-house isolates in microbiological QC testing
- The selection and implementation of in-house isolates
- Common microorganisms isolated in pharma labs.
You’ll also learn about four common isolates frequently requested to be converted into BIOBALL® format as part of bioMerieux’s BIOBALL® Custom Services.
We hope you find the information useful!
Please register your details to read this application note in full.
